These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25304345)

  • 21. Regulation of GPCR signal networks via membrane trafficking.
    Jean-Alphonse F; Hanyaloglu AC
    Mol Cell Endocrinol; 2011 Jan; 331(2):205-14. PubMed ID: 20654691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy.
    Zalewska M; Siara M; Sajewicz W
    Acta Pol Pharm; 2014; 71(2):229-43. PubMed ID: 25272642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G-protein-coupled designer receptors - new chemical-genetic tools for signal transduction research.
    Thiel G; Kaufmann A; Rössler OG
    Biol Chem; 2013 Dec; 394(12):1615-22. PubMed ID: 23893685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
    Sankararamakrishnan R
    Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands.
    Goetzl EJ
    FASEB J; 2007 Mar; 21(3):638-42. PubMed ID: 17194692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissection of aberrant GPCR signaling in tumorigenesis--a systems biology approach.
    Wu J; Xie N; Zhao X; Nice EC; Huang C
    Cancer Genomics Proteomics; 2012 Jan; 9(1):37-50. PubMed ID: 22210047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptors and ionic transporters in nuclear membranes: new targets for therapeutical pharmacological interventions.
    Bkaily G; Avedanian L; Al-Khoury J; Ahmarani L; Perreault C; Jacques D
    Can J Physiol Pharmacol; 2012 Aug; 90(8):953-65. PubMed ID: 22783834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors.
    Lohse MJ; Nikolaev VO; Hein P; Hoffmann C; Vilardaga JP; Bünemann M
    Trends Pharmacol Sci; 2008 Mar; 29(3):159-65. PubMed ID: 18262662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
    Wada M; Kanamori E; Nakamura H; Fukunishi Y
    J Chem Inf Model; 2011 Sep; 51(9):2398-407. PubMed ID: 21848279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-displayed peptide ligand activates the pheromone response pathway in Saccharomyces cerevisiae.
    Hara K; Ono T; Kuroda K; Ueda M
    J Biochem; 2012 May; 151(5):551-7. PubMed ID: 22406406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.
    Hsu SH; Luo CW
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1021-9. PubMed ID: 17652154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conserved activation pathways in G-protein-coupled receptors.
    Deupi X; Standfuss J; Schertler G
    Biochem Soc Trans; 2012 Apr; 40(2):383-8. PubMed ID: 22435816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective covalent labeling of tag-fused GPCR proteins on live cell surface with a synthetic probe for their functional analysis.
    Nonaka H; Fujishima SH; Uchinomiya SH; Ojida A; Hamachi I
    J Am Chem Soc; 2010 Jul; 132(27):9301-9. PubMed ID: 20568758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Ras and Rho GTPases and MAP Kinases by G-protein-coupled receptors.
    Chiariello M; Vaqué JP; Crespo P; Gutkind JS
    Methods Mol Biol; 2010; 661():137-50. PubMed ID: 20811981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
    Gilchrist A
    Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GoLoco motif peptides as probes of Galpha subunit specificity in coupling of G-protein-coupled receptors to ion channels.
    Oxford GS; Webb CK
    Methods Enzymol; 2004; 390():437-50. PubMed ID: 15488193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptides as active probes.
    Undén A; Bartfai T
    EXS; 1995; 73():229-55. PubMed ID: 7579975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme-activated anchoring of peptide probes onto plasma membranes for selectively lighting up target cells.
    Xia J; Sun S; Wu X; Huang Y; Lei C; Nie Z
    Analyst; 2020 May; 145(10):3626-3633. PubMed ID: 32350495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.